Pharmacy Articles

Pharmacy

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Rougemont M et al. – Pharmacy–refill adherence might be considered as an alternative to CD4 count monitoring for identification of patients at risk of virological failure, especially in resources–scarce countries. The study confirmed the difficulty in demonstrating clear associations of individual patient factors and treatment outcomes. The substantial loss to follow–up and deaths occurring within 6 months after initiating ART emphasise the need to understand the best timing of ART initiation and further elucidate and educate on the underlying reasons for delaying initiation of ART in resource–limited countries.

Related Articles

Ethical Challenges In Long-Term Funding For HIV/AIDS
Health Affairs, 11/18/09    Relevance Score: 66%

Treatment partners and adherence to HAART in Central Mozambique
AIDS Care, 11/06/09    Relevance Score: 66%

Effective Treatment of Patients in a Deep Salvage Situation with Non-Active HAART: Experiences with the Expert Advice System RADATA
Infection, 11/04/09    Relevance Score: 66%

In vivo evidence that truncated trkB.T1 participates in nociception
Molecular Pain, 10/30/09    Relevance Score: 65%

Perinatal acquisition of drug-resistant HIV-1 infection: mechanisms and long-term outcome
Retrovirology, 10/05/09    Relevance Score: 65%

Today in Antimicrobials...keeping you current

Investigational drugs for hepatitis C
Expert Opinion on Investigational Drugs, 12/15/09

Treatment of vancomycin-intermediate Staphylococcus aureus (VISA) endocarditis with linezolid
International Journal of Infectious Diseases, 12/15/09

The efficacy of Echinacea in a 3-D tissue model of human airway epithelium
Phytotherapy Research, 12/15/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address